Shiqi Chen

SIRT3 as a potential therapeutic target for heart failure.

Jie Chen, Shiqi Chen, Bingxia Zhang, 2021, Pharmacological research.

Chemo-drugs in cell microparticles reset antitumor activity of macrophages by activating lysosomal P450 and nuclear hnRNPA2B1

Hua-Chuan Zhang, Yi Zhang, P. Xu, 2023, Signal Transduction and Targeted Therapy.

End-of-treatment anti-HBs levels and HBeAg status identify durability of HBsAg loss after PEG-IFN discontinuation

Jiming Zhang, Jingjing He, Yifei Guo, 2023, Frontiers in Cellular and Infection Microbiology.

Inhibition of HBV replication by EVA1A via enhancing cellular degradation of HBV components and its potential therapeutic application.

Mengji Lu, Jiming Zhang, Zhenghong Yuan, 2023, Antiviral research.

Clinical isolates of hepatitis B virus genotype C have higher in vitro transmission efficiency than genotype B isolates

Jiming Zhang, S. Tong, Jisu Li, 2023, Journal of medical virology.

Evolving spike mutations in SARS-CoV-2 Omicron variants facilitate evasion from breakthrough infection-acquired antibodies

Jiming Zhang, T. Cheng, Q. Yuan, 2023, Cell discovery.

Incidence and severity of SARS‐CoV‐2 reinfection, a multicenter cohort study in Shanghai, China

Jiming Zhang, R. Mao, Feifei Yang, 2023, Journal of medical virology.